Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-26

Clinical Trial Update: Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing monotherapy with levetiracetam versus carbamazepine in patients with epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keppra (levetiracetam)
  • TEGRETOL (CARBAMAZEPINE)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Tonic-clonic | Phase 3 | Status: COMPLETED